Roche says Avastin phase III study shows positive results in women with advanced ovarian cancer
Saturday, February 27, 2010 11:00 IST Basel
Roche announced that a phase-III study showed the combination of Avastin (bevacizumab) and chemotherapy followed by maintenance use of Avastin increased the time women with